Defining the key intrahepatic gene networks in HCV infection driven by sex.
BIOSTATISTICS
GENE EXPRESSION
HEPATITIS C
INFECTIOUS DISEASE
INFLAMMATION
Sex immunology
Journal
Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
02
11
2021
accepted:
30
04
2022
medline:
6
4
2023
pubmed:
26
5
2022
entrez:
25
5
2022
Statut:
ppublish
Résumé
The transcriptional response in the liver during HCV infection is critical for determining clinical outcomes. This issue remains relatively unexplored as tissue access to address this at scale is usually limited. We aimed to profile the transcriptomics of HCV-infected livers to describe the expression networks involved and assess the effect on them of major predictors of clinical outcome such as IFNL4 (interferon lambda 4) host genotype and sex. We took advantage of a large clinical study of HCV therapy accompanied by baseline liver biopsy to examine the drivers of transcription in tissue samples in 195 patients also genotyped genome-wide for host and viral single nucleotide polymorphisms. We addressed the role of host factors (disease status, sex, genotype, age) and viral factors (load, mutation) on transcriptional responses. We observe key modules of transcription which can be impacted differentially by host and viral factors. Underlying cirrhotic state had the most substantial impact, even in a stable, compensated population. Notably, sex had a major impact on antiviral responses in concert with IL28B (interleukin 28B)/IFNL4 genotype, with stronger interferon and humoral responses in females. Males tended towards a dominant cellular immune response. In both sexes, there was a strong influence of the underlying host disease status and of specific viral mutations, and sex-specific expression quantitative trait loci were also observed. These features help define the major influences on tissue responses in HCV infection, impacting on the response to treatment and with broader implications for responses in other sex-biased infections.
Identifiants
pubmed: 35613843
pii: gutjnl-2021-326314
doi: 10.1136/gutjnl-2021-326314
pmc: PMC10086281
doi:
Substances chimiques
Interleukins
0
Antiviral Agents
0
Ribavirin
49717AWG6K
IFNL4 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
984-994Subventions
Organisme : Medical Research Council
ID : MR/K01532X/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT109965MA
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220171/Z/20/Z
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Hepatol. 2014 Nov;61(1 Suppl):S45-57
pubmed: 25086286
BMC Bioinformatics. 2014 Jun 12;15:182
pubmed: 24925680
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Front Immunol. 2018 Oct 08;9:2302
pubmed: 30349537
Int J Oncol. 2005 Feb;26(2):369-77
pubmed: 15645121
PLoS One. 2020 Feb 21;15(2):e0229345
pubmed: 32084211
J Infect Dis. 2015 Nov 1;212(9):1407-19
pubmed: 25883387
Hepatology. 2014 Jan;59(1):109-20
pubmed: 23908124
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
PLoS One. 2015 Jul 30;10(7):e0134529
pubmed: 26226615
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
BMC Bioinformatics. 2016 Nov 25;17(1):483
pubmed: 27884101
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
BMC Biotechnol. 2013 Nov 20;13:104
pubmed: 24256843
Ann N Y Acad Sci. 2012 May;1256:E1-22
pubmed: 23025408
Antimicrob Agents Chemother. 2014 May;58(5):2781-97
pubmed: 24590484
Sci Rep. 2020 Mar 20;10(1):5088
pubmed: 32198464
Nat Genet. 2017 May;49(5):666-673
pubmed: 28394351
Hepatology. 2004 Dec;40(6):1426-33
pubmed: 15565616
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Nat Methods. 2013 Nov;10(11):1096-8
pubmed: 24056875
PLoS One. 2013 Jul 18;8(7):e68992
pubmed: 23874843
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1828-33
pubmed: 16446426
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Front Immunol. 2016 Dec 23;7:628
pubmed: 28066437
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Commun. 2022 Jan 12;13(1):269
pubmed: 35022412
PLoS One. 2011;6(11):e27555
pubmed: 22110669
Cell Immunol. 2004 Nov-Dec;232(1-2):144-56
pubmed: 15882859
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
Cell Rep. 2014 Nov 6;9(3):1075-88
pubmed: 25437561
Nutrients. 2019 Jan 04;11(1):
pubmed: 30621171
Bioinformatics. 2006 Aug 1;22(15):1928-9
pubmed: 16720584
Sci Rep. 2022 Jan 10;12(1):462
pubmed: 35013427
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Liver Int. 2017 May;37(5):669-677
pubmed: 27885811
Hepatology. 2018 Sep;68(3):859-871
pubmed: 29534310
Gastroenterology. 2010 Jul;139(1):120-9.e18
pubmed: 20399780
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Gastroenterology. 2015 Nov;149(6):1462-70
pubmed: 26248087
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513